Ezia Bello

1.4k total citations
36 papers, 922 citations indexed

About

Ezia Bello is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ezia Bello has authored 36 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ezia Bello's work include Nanoparticle-Based Drug Delivery (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Fibroblast Growth Factor Research (4 papers). Ezia Bello is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Fibroblast Growth Factor Research (4 papers). Ezia Bello collaborates with scholars based in Italy, Spain and Switzerland. Ezia Bello's co-authors include Maurizio D’Incalci, Roberta Frapolli, Massimo Zucchetti, Carlos M. Galmarini, Sergio Marchini, Eugenio Erba, Giovanna Damia, Luca Beltrame, Paola Allavena and Simonetta Andrea Licandro and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Ezia Bello

34 papers receiving 905 citations

Peers

Countries citing papers authored by Ezia Bello

Since Specialization

Citations

This map shows the geographic impact of Ezia Bello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezia Bello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezia Bello more than expected).

Fields of papers citing papers by Ezia Bello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezia Bello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezia Bello. The network helps show where Ezia Bello may publish in the future.

Co-authorship network of co-authors of Ezia Bello

This figure shows the co-authorship network connecting the top 25 collaborators of Ezia Bello. A scholar is included among the top collaborators of Ezia Bello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezia Bello. Ezia Bello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody 2025 ·Cancer Immunology Immunotherapy ·(unknown), Irene Cattaneo, Rut Valgardsdottir, Roberta Frapolli, Ezia Bello, (unknown), Andrea Gianatti, (unknown), Paola Rizzo, Susanna Tomasoni, Maurizio D’Incalci, Martino Introna, Josée Golay, Alessandro Rambaldi	0
2	Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide 2024 ·Pharmaceutics ·Cristina Matteo, Isabella Orienti, Adriana Eramo, Ann Zeuner, (unknown), Alice Passoni, Renzo Bagnati, (unknown), Ezia Bello, Massimo Zucchetti, Roberta Frapolli	2
3	Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites 2024 ·Journal of Experimental & Clinical Cancer Research ·Ilaria Craparotta, Laura Mannarino, (unknown), (unknown), Sergio Marchini, Giulio Pavesi, Marta Russo, Salvatore Lorenzo Renne, (unknown), (unknown), Ezia Bello, Roberta Sanfilippo, Paolo G. Casali, Maurizio D’Incalci, Roberta Frapolli	0
4	Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages 2023 ·Advanced Healthcare Materials ·María Sancho‐Albero, Giorgio Facchetti, Nicolò Panini, (unknown), Ezia Bello, Isabella Rimoldi, Massimo Zucchetti, Roberta Frapolli, Luisa De Cola	13
5	Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging 2021 ·Talanta ·Lavinia Morosi, Cristina Matteo, (unknown), Tommaso Ceruti, Ilaria Fuso Nerini, Ezia Bello, Roberta Frapolli, Maurizio D’Incalci, Massimo Zucchetti, Enrico Davoli	12
6	Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 2021 ·Genomics ·Laura Mannarino, Ilaria Craparotta, (unknown), Roberta Frapolli, (unknown), Ezia Bello, Nicolò Panini, Maurizio Callari, Roberta Sanfilippo, Paolo G. Casali, Marta Barisella, Chiara Fabbroni, Sergio Marchini, Maurizio D’Incalci	6
7	Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas 2019 ·Clinical Cancer Research ·Roberta Frapolli, Ezia Bello, (unknown), Ilaria Craparotta, Laura Mannarino, (unknown), Sergio Marchini, Laura Carrassa, Paolo Ubezio, Luca Porcu, Silvia Brich, Roberta Sanfilippo, Paolo G. Casali, Alessandro Gronchi, Silvana Pilotti, Maurizio D’Incalci	20
8	Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin 2019 ·British Journal of Cancer ·Ezia Bello, Silvia Brich, Ilaria Craparotta, Laura Mannarino, (unknown), Raffaella Gatta, Sergio Marchini, Laura Carrassa, Cristina Matteo, Roberta Sanfilippo, Alessandro Gronchi, Paolo G. Casali, Silvana Pilotti, Maurizio D’Incalci, Roberta Frapolli	12
9	A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells 2019 ·Journal of Experimental & Clinical Cancer Research ·Isabella Orienti, Valentina Salvati, Giovanni Sette, Massimo Zucchetti, Lucilla Bongiorno‐Borbone, Angelo Peschiaroli, Lello Zolla, Federica Francescangeli, (unknown), Cristina Matteo, Ezia Bello, Antonio Di Virgilio, Mario Falchi, Maria Laura De Angelis, Marta Baiocchi, Gerry Melino, Ruggero De Maria, Ann Zeuner, Adriana Eramo	36
10	Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin 2018 ·Journal of Controlled Release ·Umberto Capasso Palmiero, Lavinia Morosi, Ezia Bello, (unknown), Roberta Frapolli, Cristina Matteo, (unknown), Massimo Zucchetti, Lucia Minoli, Marcella De Maglie, (unknown), Massimo Morbidelli, Maurizio D’Incalci, Davide Moscatelli	11
11	Self‐Assembling PCL‐Based Nanoparticles as PTX Solubility Enhancer Excipients 2018 ·Macromolecular Bioscience ·Umberto Capasso Palmiero, Lavinia Morosi, Monica Lupi, (unknown), Roberta Frapolli, Massimo Zucchetti, Paolo Ubezio, Massimo Morbidelli, Maurizio D’Incalci, Ezia Bello, Davide Moscatelli	9
12	In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models 2016 ·Neoplasia ·Federica Guffanti, Rosaria Chilà, Ezia Bello, Massimo Zucchetti, (unknown), (unknown), (unknown), Monica Lupi, (unknown), Mike F. Burbridge, (unknown), Giovanna Damia	25
13	A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma 2014 ·Nanotechnology ·Monica Lupi, Claudio Colombo, Roberta Frapolli, Raffaele Ferrari, Leopoldo Sitia, (unknown), Ezia Bello, Simonetta Andrea Licandro, Francesca Falcetta, Paolo Ubezio, Paolo Bigini, Mario Salmona, Maurizio D’Incalci, Massimo Morbidelli, Davide Moscatelli	20
14	The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts 2012 ·Molecular Cancer Therapeutics ·Ezia Bello, Giulia Taraboletti, Gennaro Colella, Massimo Zucchetti, (unknown), Simonetta Andrea Licandro, Alexander Berndt, Petra Richter, Maurizio D’Incalci, Ennio Cavalletti, Raffaella Giavazzi, Gabriella Camboni, Giovanna Damia	39
15	Assessing the anti-tumour properties of Iraqi propolis in vitro and in vivo 2012 ·Food and Chemical Toxicology ·Ghassan M. Sulaiman, Ali H. Ad’hiah, (unknown), Renzo Bagnati, Roberta Frapolli, Ezia Bello, Sarah Uboldi, Michela Romano, Nicolò Panini, Eugenio Scanziani, Marzia Pezzolato, Eugenio Erba, Maurizio D’Incalci	30
16	E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models 2011 ·Cancer Research ·Ezia Bello, Gennaro Colella, (unknown), Paolo Oliva, Alexander Berndt, Giovanni Valbusa, Sonia Colombo Serra, Maurizio D’Incalci, Ennio Cavalletti, Raffaella Giavazzi, Giovanna Damia, Gabriella Camboni	117
17	Chemical characterization of Iraqi propolis samples and assessing their antioxidant potentials 2011 ·Food and Chemical Toxicology ·Ghassan M. Sulaiman, (unknown), Ali H. Ad’hiah, Massimo Zucchetti, Roberta Frapolli, Ezia Bello, Eugenio Erba, Maurizio D’Incalci, Renzo Bagnati	77
18	The Neuroprotective Effect of Erythropoietin in Docetaxel-Induced Peripheral Neuropathy Causes No Reduction of Antitumor Activity in 13762 Adenocarcinoma-Bearing Rats 2009 ·Neurotoxicity Research ·Ilaria Cervellini, Ezia Bello, Roberta Frapolli, Carla Porretta‐Serapiglia, N Oggioni, A Canta, Raffaella Lombardi, Francesca Camozzi, Ilaria Roglio, Roberto Cosimo Melcangi, Maurizio D’Incalci, Giuseppe Lauria, Pietro Ghezzi, Guido Cavaletti, Roberto Bianchi	21
19	Clinical pharmacokinetics of the new oral camptothecin gimatecan: The inter-patient variability is related to α1-acid glycoprotein plasma levels 2009 ·European Journal of Cancer ·Roberta Frapolli, Massimo Zucchetti, Cristiana Sessa, Silvia Marsoni, Lucia Viganò, Alberta Locatelli, Eliana Rulli, Anna Compagnoni, Ezia Bello, Claudio Pisano, Paolo Carminati, Maurizio D’Incalci	7
20	Detection of tissue‐specific effects by methotrexate on differentiating mouse embryonic stem cells 2004 ·Birth Defects Research Part B Developmental and Reproductive Toxicology ·Cristian Pellizzer, Ezia Bello, Sarah Adler, Thomas Härtung, Susanne Bremer	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact